tirzepatide surmount once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Effect of tirzepatide in SURMOUNT-1

CAS Number: 170851-70-4 Molar Mass: Approximately 711.86 g/mol Chemical Formula: C38H49N9O5 IUPAC Name: (2S)-2-Amino-3-(4-hydroxy-1,2,3-triazol-1-yl)-N-(2,2-dimethylpropanoyl)-2-[(1R)-2-[(1S)-2-[(2S)-2-amino-3-(4-hydroxy-1,2,3-triazol-1-yl)propanoylamino]-3-(1H-indol-3-yl)propanoylamino]-3-methylbutanoyl]propanamide Synonyms: Ipamorelin is also known by its developmental code name, MK-677

It supports better patient outcomes, justifies clinical decisions, and creates an objective data trail for long-term metabolic management

With MASH serving as a leading cause of liver transplants globally, this regulatory fast-track offers immense hope for millions lacking viable treatment options

Experience in severe impairment is limited